MentionFox
Home › funding signals › Shasqi
Accelerator · announced

Shasqi (YC W15) — Targeting cancer with click chemistry

Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug.

Shasqi is a Y Combinator company in the Winter 2015 batch. Its directory entry describes it as: Targeting Cancer with Click Chemistry. The founder listed is Jose M. Mejia Oneto (Founder/CEO) (Y Combinator directory entry, January 13, 2015).

6 more companies from YC Winter 2015 ↓

Run the free check on Shasqi →

Sell to companies like Shasqi? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Shasqi

New accelerator entry · 2015-01-13 · the record

Winter 2015
batch
28
people
Growth
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2015
Announced2015-01-13
StageGrowth
StatusActive
Team size28
IndustryHealthcare
Sub-industryHealthcare -> Drug Discovery and Delivery
SectorsBiotech, Therapeutics
RegionsUnited States of America, America / Canada, Remote, Fully Remote
BasedSan Francisco, CA, USA; Remote
HiringNo
Founded2015
Previously known asShasqi, Tambo

Pitching, partnering or investing alongside them? See who really runs and owns Shasqi.

Free to see. No signup.

Keep reading

More on Shasqi and the records around it.

Also in YC Winter 2015

Same batch, Healthcare first.

What do you want to do with Shasqi?

Get the full cited report on Shasqi

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Shasqi: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.

Want the whole picture on Shasqi?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Shasqi: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Shasqi covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Shasqi: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Shasqi. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Shasqi: Accepted into Y Combinator Winter 2015
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-shasqi
Last updated 2026-10-27
Primary record: Y Combinator directory entry
Shasqi (YC W15) — Targeting cancer with click chemistry. MentionFox, 2026-10-27. https://mentionfox.com/funding/yc-shasqi